Search results
Results from the WOW.Com Content Network
The Swiss pharma giant reported fourth-quarter adjusted earnings per share of $1.98, beating the street view of $1.81. ... Dividend: Novartis declared a dividend of CHF3.50 per share, an increase ...
For premium support please call: 800-290-4726 more ways to reach us
The Swiss pharma giant reported adjusted EPS of $2.06, up from $1.74 a year ago and beating the consensus of $1.96 Core operating profit for the third quarter grew to $5.15 billion from $4.41 ...
The biopharmaceutical unit was integrated into Novartis Pharmaceuticals, while the vaccines and blood testing units were made into a new Novartis Vaccines and Diagnostics division. [34] Also in 2006, Sandoz became the first company to have a biosimilar drug approved in Europe with its recombinant human growth hormone drug.
Advanced Accelerator Applications (AAA or Adacap) is a France-based pharmaceutical group, specialized in the field of nuclear medicine. [1] The group operates in all three segments of nuclear medicine (PET, SPECT and therapy) to diagnose and treat serious conditions in the fields of oncology, neurology, cardiology, infectious and inflammatory diseases.
Jimenez joined Novartis in 2007 as Division Head of Novartis Pharmaceutical and was named CEO in 2010 [7] by his predecessor and Chairman Daniel Vasella. [8]During his time at Novartis, Jimenez increasingly applied standard business metrics to pharma cash flow, purchasing and competitive bidding, confident that his experience in consumer goods would help to realize improvements in Novartis ...
If you want to see more stocks in this selection, check out 5 Best Pharma Dividend Stocks To Buy. As per a Bloomberg report dated September 12, the global bio-pharma market was valued at $274.10 ...
This is a list of publicly traded companies that offer their shareholders the option to be paid with scrip dividends. Name Country ACS [1] Spain: Banco Santander [2]